首页> 外文期刊>Heart >Percutaneous repair of paravalvular prosthetic regurgitation: patient selection, techniques and outcomes
【24h】

Percutaneous repair of paravalvular prosthetic regurgitation: patient selection, techniques and outcomes

机译:经皮修复瓣周假体返流:患者选择,技术和结果

获取原文
获取原文并翻译 | 示例
           

摘要

Paravalvular prosthetic regurgitation is common, affecting 5-10% of surgical prostheses and 40-70% of transcatheter valves. While many patients may suffer no significant morbidity, paravalvular prosthetic regurgitation can lead to heart failure and haemolytic anaemia, and, in some studies, has been associated with impaired survival. Over the past several years, percutaneous repair of paravalvular prosthetic regurgitation has been demonstrated to be a highly efficacious therapy. When performed in experienced centres, procedural success with percutaneous repair occurs in 90% of patients. Due to the complex nature of the techniques, there is a significant learning curve with a high potential for prolonged procedures (~2.5 h) and complications (~5%), although death is rare (~0.5%). Percutaneous repair of paravalvular prosthetic regurgitation requires a close collaboration between imaging specialists, surgeons and the interventional operators. Importantly, successful percutaneous repair obviates the need for open surgical correction, which can be high risk or prohibitive due to the need for reoperation in the setting of comorbidities. Herein, we discuss appropriate patient selection, the catheter-based techniques and outcomes of percutaneous repair for symptomatic paravalvular prosthetic regurgitation.
机译:瓣周假体返流很常见,影响了5-10%的手术假体和40-70%的经导管瓣膜。尽管许多患者可能没有明显的发病率,但瓣周假体返流可导致心力衰竭和溶血性贫血,并且在一些研究中,其与生存期受损有关。在过去的几年中,经皮修复瓣周假体返流已被证明是一种高效的疗法。在经验丰富的中心进行手术时,90%的患者经皮修复手术成功。由于技术的复杂性,尽管死亡很少(〜0.5%),但存在一条很长的学习曲线,具有延长手术时间(〜2.5 h)和并发症(〜5%)的巨大潜力。经皮修复瓣膜周围假体反流需要影像专家,外科医生和介入操作者之间的密切合作。重要的是,成功的经皮修复消除了对开放手术矫正的需要,由于合并症的发生需要重新手术,开放手术矫正可能是高风险的或禁止的。本文中,我们讨论了适当的患者选择,基于导管的技术以及有症状的瓣周假体返流的经皮修复的效果。

著录项

  • 来源
    《Heart》 |2015年第9期|665-673|共9页
  • 作者单位

    Center for Valve and Structural Heart Disease, Minneapolis Heart Institute, Abbott Northwestern Hospital, 920 East 28th ST, Minneapolis, MN 55407, USA;

    Center for Valve and Structural Heart Disease, Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA;

    Center for Valve and Structural Heart Disease, Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA;

    Center for Valve and Structural Heart Disease, Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号